Off-Label Promotion Not Enough For Fed Intervention – Patton Boggs Lawyer

Promotion of off-label applications alone will rarely trigger a U.S. Department of Justice investigation of a drug or device manufacturer, according to Patton Boggs partner Laura Laemmle